Literature DB >> 27234209

In vitro effect of sodium arsenite on Echinococcus granulosus protoscoleces.

Guoqiang Xing1, Bo Wang1, Ying Lei2, Chunli Liu3, Zhuo Wang1, Hongjuan Shi2, Rentan Yang1, Wenjuan Qin2, Yufeng Jiang4, Hailong Lv5.   

Abstract

Cystic echinococcosis (CE) caused by the metacestodes of Echinococcus granulosus is an important cosmopolitan zoonosis. Surgery is the main treatment option for CE. Meanwhile, chemotherapy is used as an significant adjunct to surgery. However, the benzimidazole carbamate group and the existing scolicidal agents may not be as effective as hoped. In this study, we aimed to explore the in vitro effect of sodium arsenite (NaAsO2) on Echinococcus granulosus protoscoleces, the causative agents of CE. Protoscoleces of E. granulosus were incubated in vitro with 4, 8, 12, 16, and 20μM NaAsO2. Viability and changes in morphology were investigated by 0.1% eosin staining. The ultrastructural alterations were observed by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). Additionally, caspase-3 activity was measured by colorimetric assay. Obvious protoscolicidal effect was seen with NaAsO2 at concentrations of 16μM and 20μM. Protoscolex mortality was 83.24% (16μM) and 100% (20μM) after 6 days post-incubation. SEM showed that the primary site of drug damage was the tegument of the protoscoleces. TEM analysis demonstrated that the internal tissues were severely affected and revealed an increase in the number of lipid droplets and vacuoles after treatment with 16μM NaAsO2. Meanwhile, the caspase-3 activity significantly increased in protoscoleces after 24h of NaAsO2 incubation compared to the untreated controls. Our study demonstrated the clear in vitro scolicidal effect of NaAsO2 against E. granulosus protoscoleces. However, the in vivo efficacy, specific mechanism, and any possible side effects of NaAsO2 remain to be investigated.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Echinococcus granulosus; In vitro; Protoscoleces; Sodium arsenite

Mesh:

Substances:

Year:  2016        PMID: 27234209     DOI: 10.1016/j.molbiopara.2016.05.011

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  2 in total

1.  Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.

Authors:  Mar Siles-Lucas; Adriano Casulli; Roberto Cirilli; David Carmena
Journal:  PLoS Negl Trop Dis       Date:  2018-04-20

Review 2.  Recent advances on innate immune pathways related to host-parasite cross-talk in cystic and alveolar echinococcosis.

Authors:  Nayer Mehdizad Bakhtiar; Adel Spotin; Mahmoud Mahami-Oskouei; Ehsan Ahmadpour; Ali Rostami
Journal:  Parasit Vectors       Date:  2020-05-06       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.